Concepedia

Author

Jérôme Rey

Institut Paoli-Calmettes

Also Known As

Angela Granata, Bilal Mohty, Catherine Lacombe, E. d’Incan, Evelyne D’Incan, J P Rey, J POLONOVSKI, J REY, J Rey, J. P. Rey

170

Publications

3.4K

Citations

32

H-Index

93

Concepts

All Affiliations

Institut Paoli-CalmettesInsermCentre de Recherche en Cancérologie de MarseilleAix-Marseille UniversitéAssistance Publique – Hôpitaux de Paris
JR

About

Jérôme Rey is an author at Institut Paoli-Calmettes specializing in medicine, pathology, and immunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

18

779

2

Natural Sciences

2

2

62

3

Allergy

2

2

60

4

Health Sciences

1

1

327

5

Public Health

1

1

14

Jérôme Rey

×

43

Publications

2.3K

Citations

27

H-Index

YearCitations

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev,

The Lancet Haematology

2020

327

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases

Benoît Bareau, Jérôme Rey, M. Hamidou,

Haematologica

2010

213

Mutation analysis of <i>ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12,</i> and <i>TET2</i> in myeloproliferative neoplasms

Mandy Brecqueville, Jérôme Rey, François Bertucci,

Genes Chromosomes and Cancer

2012

151

A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies

Norbert Vey, Lionel Karlin, Sophie Sadot‐Lebouvier,

Oncotarget

2018

134

Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients

Florent Malard, Anne Vekhoff, Simona Lapusan,

Nature Communications

2021

88

Efficacy and safety of pegylated‐interferon α‐2a in myelofibrosis: a study by the <scp>FIM</scp> and <scp>GEM</scp> French cooperative groups

Jean‐Christophe Ianotto, Françoise Boyer‐Perrard, Emmanuel Gyan,

British Journal of Haematology

2013

78

Efficacy Results of a 52-Week, Randomised, Double-Blind, Safety Study of a Calcipotriol/Betamethasone Dipropionate Two-Compound Product (Daivobet®/Dovobet®/Taclonex®) in the Treatment of Psoriasis Vulgaris

Knud Kragballe, Joar Austad, L. Barnes,

Dermatology

2006

74

Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of <i>ASXL1</i> mutations: a FIM study

Damien Luque Paz, Jérémie Riou, Emmanuelle Verger,

Blood Advances

2021

70

Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms

Geoffroy Venton, Frédéric Courtier, Aude Charbonnier,

American Journal of Hematology

2017

69

Natural Killer Defective Maturation Is Associated with Adverse Clinical Outcome in Patients with Acute Myeloid Leukemia

Anne-Sophie Chrétien, Cyril Fauriat, Florence Orlanducci,

Frontiers in Immunology

2017

68

Page 1